Ivx Health
Provides biologic injections and infusions to patients.
Based in TN
AI Overview
With $200K in lobbying spend across 6 quarterly filings, Ivx Health is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2019 to 2020.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $80K |
| 2020 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ivx Health disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Taxation, Health Issues
Medicare Part B payment reform.
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act, and H.R. 3, the Lower Drug Costs Now Act. International Pricing Index model (83 FR 54546).
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, H.R. 3, the Lower Drug Costs Now Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. Intern
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. International Pricing Index model (83 FR 54546). Sup
Inclusion of COBRA subsidy in coronavirus relief legislation.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.